Project Number 3RF1AG057443-01S1 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Expanding AMP-AD Target Enabling Packages to identify small molecule inhibitors that block protein-protein interaction Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 2. Identification and Validation of Novel Targets Researcher and Organization Principal Investigator MANGRAVITE, LARA M Principal Investigator First Name PAUL Principal Investigator Last Name BRENNAN Awardee Organization SAGE BIONETWORKS Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) FY Overall Cost $202,186 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Target Discovery and Preclinical Validation Project
